These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9684792)

  • 1. Cleavage requirements of factor V in tissue-factor induced thrombin generation.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Thromb Haemost; 1998 Jul; 80(1):92-8. PubMed ID: 9684792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage requirements for activation of factor V by factor Xa.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Eur J Biochem; 1997 Jul; 247(1):12-20. PubMed ID: 9249003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional properties of recombinant factor V mutated in a potential calcium-binding site.
    Sørensen KW; Nicolaes GA; Villoutreix BO; Yamazaki T; Tans G; Rosing J; Dahlbäck B
    Biochemistry; 2004 May; 43(19):5803-10. PubMed ID: 15134454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the tissue factor pathway in initiation of coagulation.
    Mann KG; van't Veer C; Cawthern K; Butenas S
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S3-7. PubMed ID: 9819022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimerin 1 binds factor V and activated factor V with high affinity and inhibits thrombin generation.
    Jeimy SB; Fuller N; Tasneem S; Segers K; Stafford AR; Weitz JI; Camire RM; Nicolaes GA; Hayward CP
    Thromb Haemost; 2008 Dec; 100(6):1058-67. PubMed ID: 19132231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T; Blezer R; Hemker HC
    Thromb Haemost; 1990 Nov; 64(3):464-8. PubMed ID: 2096492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an inactivating cleavage site for alpha-thrombin on the heavy chain of factor Va.
    Erdogan E; Bukys MA; Orfeo T; Mann KG; Kalafatis M
    Thromb Haemost; 2007 Nov; 98(5):998-1006. PubMed ID: 18000604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma.
    Duchemin J; Pan-Petesch B; Arnaud B; Blouch MT; Abgrall JF
    Thromb Haemost; 2008 Apr; 99(4):767-73. PubMed ID: 18392335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell-based model of thrombin generation.
    Roberts HR; Hoffman M; Monroe DM
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():32-8. PubMed ID: 16673264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line.
    Isordia-Salas I; Manns JM; Sainz I; Parekh H; DeLa Cadena RA
    Thromb Res; 2005; 116(6):533-43. PubMed ID: 16181989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-mediated proteolysis of factor V resulting in gradual B-domain release and exposure of the factor Xa-binding site.
    Steen M; Dahlbäck B
    J Biol Chem; 2002 Oct; 277(41):38424-30. PubMed ID: 12163491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assay to quantify the two plasma isoforms of factor V.
    Hoekema L; Rosing J; Tans G
    Thromb Haemost; 2000 Dec; 84(6):1066-71. PubMed ID: 11154115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible mechanism of action of activated factor VII independent of tissue factor.
    Monroe DM; Hoffman M; Oliver JA; Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S15-20. PubMed ID: 9819024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in understanding the bleeding diathesis in factor V deficiency.
    Duckers C; Simioni P; Rosing J; Castoldi E
    Br J Haematol; 2009 Jun; 146(1):17-26. PubMed ID: 19438479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid region 1000-1008 of factor V is a dynamic regulator for the emergence of procoagulant activity.
    Wiencek JR; Na M; Hirbawi J; Kalafatis M
    J Biol Chem; 2013 Dec; 288(52):37026-38. PubMed ID: 24178294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of N-linked glycosylation on molecular weight, thrombin cleavage, and functional activity of human protein S.
    Lu D; Xie RL; Rydzewski A; Long GL
    Thromb Haemost; 1997 Jun; 77(6):1156-63. PubMed ID: 9241750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural models of the snake venom factor V activators from Daboia russelli and Daboia lebetina.
    Segers K; Rosing J; Nicolaes GA
    Proteins; 2006 Sep; 64(4):968-84. PubMed ID: 16807918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.